Novo is testing tiered subscriptions to boost Wegovy adherence—but whether patients stay on their meds will hinge on post-prescription support from its telehealth partners.
CVS is testing pharmacy-only stores to see if drugstores can drop snacks and still succeed as care hubs.
Its exclusive Insilico licensing reflects pharma’s move to AI-driven early discovery to speed development and trim costs.
A $10.1 billion valuation fuels its AI-driven health ambitions as Apple, Oura, and Fitbit ramp up rival features.
With Meta and Google found liable for addictive designs, healthcare marketers and doctors must prepare for concerned parents seeking guidance on preventing social media addiction in their children.
Healthcare and pharma brands must adapt digital marketing for the AI search era, make CTV actionable for older viewers, and align social strategies with how consumers discover health content.
Healthcare organizations can ease older physicians’ concerns about AI by pairing them with physician power users, starting with low-risk tasks, and holding listening sessions to gather feedback.
The move signals a consumer marketing strategy shift as GLP-1 drugs demand loyalty, engagement, and experience beyond clinical outcomes.
As Black and Hispanic consumers seek mental and broader care guidance via AI, culturally sound content becomes key for brands.
Digital formats and trusted clinical settings are turning it into a performance channel driving treatment discussions and uptake.
Merck’s nearly $7 billion acquisition bolsters its cancer portfolio as blockbuster Keytruda nears patent cliff.
When choosing where to buy prescription drugs, brand loyalty takes a back seat to price and access where they already shop.
On today’s podcast episode, we discuss what “the endless aisle” means today, how to best organize it, how AI takes it to the next level, and why the Transaction Moment matters so much. Listen to the discussion between Vice President of Content and host Suzy Davidkhanian and CEO of Rokt Catalog, Bennett Carroccio.
Many AI users change appointments, health habits, and medications after engaging with an AI tool. Health brands need content built for AI discovery.
Its partnership with Major League Baseball will give it mass reach, but real value comes from extending TV moments into digital channels.
Doctronic branding itself as an “AI doctor” will trigger tougher regulatory oversight.
Public support for regulations around warning labels and marketing restrictions raises stakes for food brands’ messaging strategies.
In today’s podcast episode, we discuss why Americans are turning to social media for health advice, the kinds of help they are seeking, and how the information they receive compares with what they hear from their offline physicians. Join Senior Director of Podcasts and host Marcus Johnson, along with Senior Analysts Rajiv Leventhal and Beth Snyder Bulik. Listen everywhere, or watch on YouTube and Spotify.
Marketers must build trust there with clear insurance support, patient assistance programs, and testimonials.
As healthier members opt out of ACA plans, insurers will be left with sicker patients who they’ll need to push toward lower-cost care.